Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pfizer reported for 6 months of 2023

8/1/23 PFE

Merck & Company reported for 6 months of 2023

8/1/23 MRK

Caterpillar reported for 6 months of 2023

8/1/23 CAT

Unipro reported for 6 months of 2023 by IFRS

8/1/23 UPRO

Fesco and Russian Railways will increase the throughput capacity of the Vladivostok seaport

8/1/23 FESH

Detsky Mir completes buyout of shares from minority shareholders via Moscow Exchange

8/1/23 DSKY

VK Play will develop Russia's largest cyber sports arena

8/1/23 VKCO

IMCB reported for 6 months of 2023 by RAS

8/1/23 GEMA

Artgen reported for 6 months of 2023 by RAS

8/1/23 ABIO

Volgogradenergosbyt reported for 6 months of 2023 by RAS

8/1/23 VGSB